Medtronic product linked to surgery problems

Wall Street Journal (subscription required), September 4, 2008
A potent substance used in spine-repair surgery to promote bone growth has been linked to life-threatening complications in dozens of patients. Many of the complications involving the product, Medtronic Inc.'s "Infuse Bone Graft," have occurred during off label uses. Medtronic representatives said it is taking the reports seriously and has been active in warning doctors of certain problems related to use of the bone graft. They added, however, that the rate of complications is low and that reports to the FDA of problems represent one-tenth of 1% of the units sold.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.